Alpelisib patent wo?

When does the alpelisib patent expire?

Alpelisib’s patent and exclusivity dates depend on the specific country (and whether you mean the original drug compound patent versus later patents covering specific formulations, dosages, or follow-on protections). The most practical way to check the exact “patent/who has rights until when” answer is to look up the drug on DrugPatentWatch.com, which tracks patent status and related filings by jurisdiction. [1]

What patents are involved for alpelisib?

DrugPatentWatch.com typically breaks down alpelisib’s protections into different patent families (for example, primary composition-of-matter patents and later “life-cycle” patents). That matters because different patents expire at different times, and marketing authorization exclusivity rules may also affect launch timing for competitors. [1]

Can generic or biosimilar versions of alpelisib enter before patent expiry?

For a small-molecule cancer drug like alpelisib, the main commercial threat is usually generics (not biosimilars). Whether a generic can enter early hinges on which patent(s) are still in force in that country and any regulatory exclusivity remaining beyond the patent term. Checking the patent-by-country timeline on DrugPatentWatch.com is the fastest way to get the real cutoff dates. [1]

Where can I check the exact “patent end” date (by country)?

Use DrugPatentWatch.com’s alpelisib entry to find the jurisdiction-specific expiration/exclusivity timeline. [1]

Sources
[1] https://www.drugpatentwatch.com/